IVF vs IUI in India 2026: Cost, Success Rates & Framework

Couples facing fertility treatment in India typically encounter both IUI (Intrauterine Insemination) and IVF (In Vitro Fertilisation) as treatment options — and often without a clear understanding of which is right for their specific situation. The cost difference is large (10-15×), the clinical indications differ significantly, and the success rate variables are not always communicated clearly.

This guide is a clinical decision framework — not a treatment recommendation. The final treatment decision rests with your treating reproductive medicine specialist after a comprehensive evaluation. ICG works with 57 IVF client centres across India — the largest IVF marketing portfolio in India — operated by Raman Soni (Performance Marketing), Hanuman Sihag (SEO), Sabhyaa (Content), Akanksha (Creative), Himanshu Ranjan (Engineering), and Abhishek (Analytics). The comparison below reflects the clinical decision logic our partner clinicians apply.

The Clinical Difference

Cost Comparison in India 2026

ICG's data from 57 IVF client centres across Indian metros (Q2 2026):

IUI cost = approximately 5-15% of IVF cost. This price differential drives many couples to attempt IUI first. The clinical question is: is IUI the right starting point for your specific situation?

Who Is IUI Right For?

IUI is typically the first-line treatment for:

1. Unexplained infertility (less than 35 years, less than 2 years trying) When all standard fertility testing returns normal results but conception has not occurred, IUI with mild stimulation is often the first-line treatment. Per-cycle success rates: 10-20%.

2. Mild male factor infertility If sperm count and motility are mildly reduced but adequate motile sperm can be recovered after washing, IUI bypasses the cervix and improves the sperm-egg encounter. Per-cycle success: 8-15%.

3. Cervical factor issues Hostile cervical mucus or anatomical cervical issues. IUI places sperm above the cervix, bypassing the issue.

4. Donor sperm conception For single women or same-sex female couples (where legally permitted under ART Act 2021), IUI with donor sperm is the standard first approach.

5. Mild endometriosis Stage I-II endometriosis without significant tubal damage may respond to IUI with stimulation.

Critical eligibility: at least one fallopian tube must be open and functional. This is confirmed via HSG (hysterosalpingography) or laparoscopy before recommending IUI.

Who Is IVF Right For?

IVF is the first-line treatment for:

1. Blocked or absent fallopian tubes IVF bypasses the tubes entirely. There is no clinical pathway through IUI when tubes are non-functional.

2. Severe male factor infertility When sperm count, motility, or morphology is severely impaired, IVF with ICSI (intracytoplasmic sperm injection) can use individual sperm injected directly into eggs.

3. Advanced maternal age (typically 38+) Egg quality declines with age. IVF allows multiple eggs to be retrieved and the best embryos selected for transfer. Time-sensitivity makes IVF the preferred direct route.

4. Severe endometriosis (Stage III-IV) Significant tubal and pelvic anatomy disruption typically requires IVF.

5. Failed multiple IUI cycles After 3-4 unsuccessful IUI cycles, IVF is generally the next step rather than continued IUI attempts.

6. Genetic conditions requiring embryo screening PGT-A (aneuploidy screening), PGT-M (single-gene disorders), and PGT-SR (structural rearrangements) require IVF.

7. Previously frozen embryos or donor cycles Frozen embryo transfer (FET) is an IVF-derived procedure.

The Cumulative Success Rate Framing

This is the most important framing concept patients miss. Single-cycle success rates can mislead.

IUI per-cycle success: 8-20% depending on age and indication. After 3-4 cycles, cumulative success approaches 40-50% in appropriate candidates.

IVF per-cycle success: Significantly higher per cycle (varies by age and clinical factors) but per-cycle rates should not be the primary comparison metric — neither IUI nor IVF should be marketed with patient-facing success rate claims (prohibited under ART Act 2021 + Schedule J).

The clinically responsible framing: "Different protocols are appropriate for different patient situations. Your treating specialist will assess your specific factors and recommend a treatment path. Individual results vary significantly based on age, ovarian reserve, sperm quality, tubal status, and other factors."

Decision Framework: The Step-Wise Approach

Most reproductive medicine specialists in India follow a step-wise approach:

Step 1: Comprehensive fertility evaluation

• Female: hormonal profile, ovarian reserve (AMH), tubal patency (HSG), ultrasound assessment
• Male: semen analysis with morphology and DNA fragmentation if indicated
• Both: thyroid, blood sugar, infection screening

Step 2: Identify any specific indication for IVF If any of the IVF-indicated conditions are present (blocked tubes, severe male factor, advanced age, severe endometriosis), proceed directly to IVF.

Step 3: If no specific IVF indication and patient is eligible for IUI Try 3-4 IUI cycles with appropriate stimulation. After 3 unsuccessful cycles, move to IVF.

Step 4: Age-appropriate urgency If maternal age is 38+, the time investment in 3-4 IUI cycles (6-12 months) may not be appropriate. Direct-to-IVF discussion is reasonable.

ART Act 2021 Compliance Note

The ART Act 2021 prohibits advertising of ART treatment success rates to the general public. Any clinic claiming specific success rates ("70% IVF success rate at our clinic") is in violation. ICG's IVF client portfolio operates strictly within ART Act framework — see our ART Act 2021 compliance guide for the full framework.

This is also why this comparison article does not include specific success rate claims. The data exists in peer-reviewed literature; this format is patient-facing and operates under ART Act + Schedule J + NMC Section 6 simultaneously.

Read next on ICG

• Complete IVF clinic marketing playbook (2026)
• ART Act 2021 IVF clinic compliance
• IVF / Fertility — industry hub
• CPQL benchmark database (15 specialties)

IVF vs IUI in India 2026: The Numbers at a Glance

Most decision-making stalls because the two procedures get compared on price alone. The honest comparison stacks cost, per-cycle success rate, cumulative outcome after three attempts, and time-to-pregnancy in one view. The table below reflects median ranges across Tier-1 and Tier-2 Indian cities as of Q3 2026, aggregated from fertility-clinic rate cards ICG audits for its Client Elevation Programme engagements.

What This Means for Fertility-Clinic Marketing

The commercial takeaway for clinic owners: the treatment ladder is a content ladder. Prospective couples researching IUI are earlier in the funnel and cost-sensitive; IVF-intent searchers are closer to a decision and price-elastic. A clinic that publishes both education tiers — with transparent cost bands and honest cumulative-success framing — captures both audiences without cannibalising either.

• Content depth: mirror the structure above (cost, success, cumulative, timeline) on every treatment page. Google's fertility-query rewrite in 2026 favours pages that answer all four in one URL.
• Local SEO: fertility is hyper-geographic. Pair educational posts with city-level landing pages managed through Angryturtle, our GBP operations system.
• Ad intelligence: IVF CPMs run 3-5x IUI in Meta auctions. Prism Spy shows which competing clinics are already bidding on which treatment intent in your city.
• Compliance guardrails: ART Act 2021 forbids success-rate advertising that is not clinic-specific and audited. Every claim needs a source line.

For fertility groups running multi-city networks, the hospital-marketing playbook covers the full stack — creative, GBP, ad intel, and CRM — under one operating rhythm.